Abstract
Ingestion of alkaloid metabolites from the bark of Galbulimima (GB) sp. leads to psychotropic and excitatory effects in humans. Only a single target, the muscarinic acetylcholine receptor, has been assigned. Limited, variable supply of GB alkaloids has im-peded their biological exploration and clinical development. Here we report a solution to the supply of GB18, a structural outlier and putative psychotropic principle of Galbulimima bark. Efficient access to the challenging tetrahedral attached-ring motif re-quired the development of a ligand-controlled endo-selective cross-electrophile coupling and a diastereoselective hydrogenation of a rotationally-dynamic pyridine. Reliable, gram-scale access to GB18 allowed its assignment as a potent antagonist of kappa- and mu- opioid receptors and lay the foundation to navigate and understand the biological activity of Galbulimima metabolites.
Supplementary materials
Title
Supporting Information
Description
Full experimental section and notes, calculations, python code, biological data (raw and processed), spectra, x-ray crystallographic data
Actions